Business Context and Reporting Period
Company: HealthSouth Corporation (Note: Input metadata listed "Encompass Health Corp," but the filing text identifies the registrant as HealthSouth Corporation).
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and six months ended June 30, 2000.
Business Overview: HealthSouth provides outpatient and rehabilitative healthcare services through inpatient and outpatient rehabilitation facilities, surgery centers, diagnostic centers, and medical centers. As of June 30, 2000, the company operated 2,036 locations across 50 states, Puerto Rico, the UK, and Australia.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2000 | Six Months Ended June 30, 1999 |
|---|---|---|
| Revenues | $2,057,658,000 | $2,078,179,000 |
| Net Income | $130,539,000 | $223,912,000 |
| Diluted EPS | $0.33 | $0.52 |
| Operating Cash Flow | $287,551,000 | $358,507,000 |
| Working Capital | $608,893,000 | $852,711,000 (Dec 31, 1999) |
| Total Debt (Long-term + Current) | $3,259,997,000 | $3,114,648,000 (Dec 31, 1999) |
| Cash and Equivalents | $170,957,000 | $129,400,000 (Dec 31, 1999) |
Margins: Operating unit expenses were 67.8% of revenues for the six months ended June 30, 2000, compared to 62.3% in the prior year period. The effective tax rate was 39.5% for the quarter ended June 30, 2000.
Material Changes vs. Prior Period
- Revenue Decline: Revenues decreased 1.0% year-over-year for the six-month period. Same-store revenues declined 2.8%, primarily due to reduced government reimbursement rates resulting from the Balanced Budget Act of 1997. Medicare revenue share dropped from 33.8% to 29.7%.
- Profitability Drop: Net income fell 41.7% to $130.5 million. Income before taxes decreased from $418.9 million to $269.3 million.
- Expense Increases: Operating unit expenses as a percentage of revenue increased significantly (62.3% to 67.8%). Corporate general and administrative expenses rose to $69.7 million (3.4% of revenue) from $56.5 million (3.0% of revenue).
- Debt Levels: Total debt increased by approximately $145 million, driven by higher borrowings under the $1.75 billion revolving credit facility (drawn up to $1.725 billion) to fund operations and acquisitions.
- Acquisitions: The company acquired 25 facilities (outpatient rehab, surgery, and diagnostic centers) for approximately $63.1 million during the first six months of 2000.
Outlook, Risks, and Management Commentary
- Capital Expenditures: Management anticipates spending $200–$250 million on maintenance/expansion and another $200–$250 million on development and e-commerce initiatives over the next 12 months.
- Debt Maturity: The company must spend $250 million to satisfy 9.5% Senior Subordinated Notes maturing on April 1, 2001. Management is pursuing refinancing opportunities.
- Reimbursement Risk: Significant exposure to changes in Medicare and Medicaid reimbursement policies. Management notes increasing pressure from payors to control costs and potential proposals to limit Medicare reimbursement.
- Legal Proceedings: The company is defending against consolidated securities class action lawsuits alleging misrepresentation of financial condition and the impact of the Balanced Budget Act. The company believes the claims are without merit but cannot predict the outcome.
- Restructuring: Approximately 96% of facilities identified for closure under the "Fourth Quarter 1998 Charge" had been closed as of July 2000.
Investor Verification Checklist
- Reimbursement Trends: Verify the specific impact of the Balanced Budget Act of 1997 on future Medicare/Medicaid reimbursement rates and the company's ability to offset these cuts with volume growth.
- Debt Refinancing: Confirm the status of refinancing the $250 million Senior Subordinated Notes due April 2001 and the terms of the $1.75 billion revolving credit facility.
- Legal Exposure: Monitor the status of the consolidated securities litigation and potential financial impact if the company's defense is unsuccessful.
- Operating Margins: Assess whether the widening gap between revenue growth and operating expense growth (67.8% expense ratio) is sustainable or indicative of deeper operational inefficiencies.
- Asset Impairment: Review the valuation of intangible assets ($2.8 billion net) given the company's history of restructuring and the sensitivity of facility valuations to reimbursement changes.